# Hikma Farmaceutica, (Portugal) S.A. – FDA Inspection, Apr 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/953b74ba-98e1-45b9-9469-1a1f573c62c3
Source feed: FDA_Inspections

> FDA inspection 1203129 of Hikma Farmaceutica, (Portugal) S.A., April 21, 2023. Classification: Voluntary Action Indicated (VAI). 14 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203129
- Company Name: Hikma Farmaceutica, (Portugal) S.A.
- Inspection Date: 2023-04-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 14

## Related Documents

- FDA Inspection 1254066 - 2023-02-03
- FDA Inspection 1125050 - 2020-03-06
- FDA Inspection 1050480 - 2018-03-22
- FDA Inspection 970483 - 2016-04-12
- [FDA Inspection 940389 - 2015-06-19](https://www.keypedia.com/records/fda_inspections/hikma-farmaceutica-portugal-sa/bbb9b354-9549-4613-bd37-f19d03ce4f52)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)

Company: https://www.keypedia.com/companies/hikma-farmaceutica-portugal-sa/39ec9f09-5b00-4a12-aa9b-2add04e825e0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
